Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies

Skin toxicity, a common drug-related adverse event observed in cancer patients treated with epidermal growth factor receptor (EGFR)-directed therapies is rarely seen with therapies targeting HER2. This study reports the significance of the EGFR and HER2 dimerization status in skin with regard to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Laux, I, Jain, A, Singh, S, Agus, D B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361091/
https://www.ncbi.nlm.nih.gov/pubmed/16306877
http://dx.doi.org/10.1038/sj.bjc.6602875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361091/
https://www.ncbi.nlm.nih.gov/pubmed/16306877
http://dx.doi.org/10.1038/sj.bjc.6602875

Ejemplares similares